UTAH MED PRODS INC shareholders Q2 2023

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 90 filers reported holding UTAH MED PRODS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

UTAH MED PRODS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Penn Mutual Asset Management, LLC 30,283$2,822,3762.54%
Clean Yield Group 30,703$2,861,5201.18%
RICE HALL JAMES & ASSOCIATES, LLC 112,999$10,531,4680.60%
Ranger Investment Management 78,681$7,333,0690.44%
Watershed Asset Management, L.L.C. 2,515$234,3980.29%
ISTHMUS PARTNERS, LLC 20,937$1,951,3280.27%
Cardinal Capital Management 11,309$1,057,3250.21%
GLOBEFLEX CAPITAL L P 9,338$870,3020.10%
Penobscot Investment Management Company, Inc. 4,000$372,8000.06%
JAMES INVESTMENT RESEARCH INC 4,292$400,0140.05%
BRANDES INVESTMENT PARTNERS, LP 23,280$2,169,6960.04%
Ancora Advisors LLC 17,182$1,601,3620.04%
ROYCE & ASSOCIATES LP 32,667$3,044,5640.03%
Legato Capital Management LLC 2,416$225,1710.03%
SEIZERT CAPITAL PARTNERS, LLC 5,912$550,9980.03%
Renaissance Technologies 203,392$18,9560.03%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 893$83,2280.02%
T. Rowe Price Investment Management, Inc. 341,118$31,7930.02%
EVERETT HARRIS & CO /CA/ 13,926$1,297,9030.02%
Annex Advisory Services, LLC 3,526$328,6570.02%
External links

This page lists UTAH MED PRODS INC's shareholders in Q2 2023. To view UTAH MED PRODS INC's shareholder history, click here.